SARA SEXSON TEJTEL to Multicenter Studies as Topic
This is a "connection" page, showing publications SARA SEXSON TEJTEL has written about Multicenter Studies as Topic.
Connection Strength
0.037
-
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease. Contemp Clin Trials. 2019 04; 79:98-103.
Score: 0.037